家族性渗出性玻璃体视网膜病变eyeGENE患者的基因型-表型谱:Norrin/β-catenin信号通路基因的新变异
本研究回顾性分析了eyeGENE数据库中来自114个家系的122例家族性渗出性玻璃体视网膜病变(FEVR)患者,对50例先证者的基因检测报告进行变异重新分类,发现Norrin/β-catenin信号通路四个基因(LRP5、FZD4、TSPAN12、NDP)共52个变异,其中35个被判为致病或可能致病,18个为新变异(34.6%),可为近三分之一(32%)先证者提供明确检测结果。TSPAN12变异患者视网膜脱离报告较少(P = 0.017),FZD4变异患者中33.3%存在不对称表现,而TSPAN12变异患者不对称性较少(11.1%)。
要点
- 在50例先证者中检出Norrin/β-catenin通路基因52个变异,35个为致病或可能致病,18个为新变异(34.6%)。
- 致病或可能致病变异可为32%的先证者提供明确检测结果,LRP5和FZD4变异最常见。
- TSPAN12变异患者视网膜脱离报告较少(P = 0.017),FZD4变异患者33.3%表现不对称,TSPAN12变异患者不对称性为11.1%。
核心结论
- 这是来自北美最大队列之一的FEVR患者回顾性分析,扩展了FEVR的变异谱。
- 在eyeGENE FEVR患者中,Norrin/β-catenin信号通路基因的疾病相关变异可解释该队列的三分之一。
- LRP5和FZD4变异最常见,基因型-表型相关性支持FEVR的表型变异性。
研究设计与样本
- 回顾性研究,纳入eyeGENE数据库中来自114个家系的122例FEVR患者。
- 临床详情和基因检测结果分别由eyeGENE网络的转诊临床医生和临床实验室提供。
- 对基因型和表型信息进行审查,并对报告的变异进行重新分类。
主要发现
- 50例先证者的基因检测报告显示Norrin/β-catenin信号通路四个基因(LRP5、FZD4、TSPAN12、NDP)共52个变异。
- 变异重新分类后,35个报告变异被判为致病或可能致病(LRP5 12个、FZD4 11个、TSPAN12 7个、NDP 5个),为近三分之一(32%)的先证者提供明确检测结果。
- 报告的变异中18个为新变异(34.6%),三分之二为错义变异。
- TSPAN12变异患者视网膜脱离报告较少(P = 0.017)。
- FZD4变异患者中三分之一(33.3%)存在不对称表现,而TSPAN12变异患者不对称性较少(11.1%)。
关键数值与推荐
- Norrin/β-catenin信号通路基因包括LRP5、FZD4、TSPAN12和NDP。
- 50例先证者中检出52个变异,重新分类后35个为致病或可能致病(LRP5 12个、FZD4 11个、TSPAN12 7个、NDP 5个)。
- 18个为新变异(34.6%),三分之二为错义变异。
- TSPAN12变异患者视网膜脱离报告较少(P = 0.017)。
- FZD4变异患者不对称表现为33.3%,TSPAN12变异患者不对称性为11.1%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To report the variants and genotype-phenotype correlations in patients with familial exudative vitreoretinopathy (FEVR) included in the eyeGENE database. METHODS: A retrospective study was conducted in a cohort of 122 eyeGENE patients from 114 families with FEVR. Clinical details and genetic test results were provided by referring clinicians and clinical laboratories in the eyeGENE network, respectively. Genotype and phenotype information was reviewed, and reported variants were reclassified. RESULTS: Genetic test reports of 50 probands revealed 52 variants in the four genes of the Norrin/β-catenin signaling pathway: LRP5, FZD4, TSPAN12, and NDP. Following variant reclassification, 35 of the reported variants were interpreted as pathogenic or likely pathogenic (12 in LRP5, 11 in FZD4, seven in TSPAN12 and five in NDP), providing a conclusive test result for nearly one-third (32%) of the probands. Among the reported variants, 18 were novel (34.6%) and two-thirds were missense. Retinal detachment was reported less in patients with variants in TSPAN12 (P = 0.017). One-third of the patients (33.3%) with an FZD4 variant had asymmetric findings. In contrast, asymmetry was less pronounced in patients with variants in TSPAN12 (11.1%). CONCLUSIONS: This was one of the largest cohorts reviewed from North America, expanding the variant spectrum in FEVR. Among the eyeGENE FEVR patients, disease-associated variants in Norrin/β-catenin signaling pathway genes can explain one-third of the cohort. LRP5 and FZD4 variants were the most common. The genotype-phenotype correlations supported the phenotypic variability in FEVR.
引用
- Yaylacioglu Tuncay F, Reeves MJ, Yousaf S, et al. Genotype-Phenotype Spectrum of eyeGENE Patients With Familial Exudative Vitreoretinopathy: Novel Variants in Norrin/β-Catenin Signaling Pathway Genes. Invest Ophthalmol Vis Sci. 2025. PMID: 39903177. doi:10.1167/iovs.66.2.9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。